5:35 PM
 | 
Aug 20, 2014
 |  BC Extra  |  Company News

TB Alliance gains Novartis tuberculosis portfolio

Novartis AG (NYSE:NVS; SIX:NOVN) granted the Global Alliance for TB Drug Development (TB Alliance) exclusive, worldwide rights...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >